Big setback for Medanta Hospital, pharmacy licence suspended after death of boy

The action against Medanta Hospital came nearly a month after the medical board submitted its report on March 5, and almost a week after the father of Saurya Pratap stated at a press conference that he accepted the reimbursement of his son’s treatment cost from Medanta Hospital, with a promise that he would not pursue legal case against the hospital.

The boy's father had alleged that the hospital had made an inflated bill of Rs 15.88 lakh, compelling him to file a case against the hospital. Image source:

The licence of Medanta Hospital’s internal pharmacy has been suspended for 7 days, following a notice issued by the Health department, said a Zee Business report today. The Gurugram hospital was found to have allegedly violated the norms when the complaint by Gopendra Pratap, the father of seven-year-old boy Saurya Pratap who died last year from a dengue infection, was being probed.

The action against Medanta Hospital came nearly a month after the medical board submitted its report on March 5, and almost a week after the father of Saurya Pratap stated at a press conference that he accepted the reimbursement of his son’s treatment cost from Medanta Hospital, with a promise that he would not pursue legal case against the hospital.

The boy's father had alleged that the hospital had made an inflated bill of Rs 15.88 lakh, compelling him to file a case against the hospital. The boy was admitted to the hospital on October 30, 2017, suffering from severe dengue with multi-organ dysfunction syndrome.

Saurya Pratap was later shifted to Ram Manohar Lohia Hospital in Delhi on November 20, as there was no improvement in his condition. He died on November 22 at the RML.

Watch this Zee Business video